188 related articles for article (PubMed ID: 31087736)
21. Gene Editing in Sorghum Through Agrobacterium.
Sander JD
Methods Mol Biol; 2019; 1931():155-168. PubMed ID: 30652289
[TBL] [Abstract][Full Text] [Related]
22. A Simple CRISPR/Cas9 System for Multiplex Genome Editing in Rice.
Wang C; Shen L; Fu Y; Yan C; Wang K
J Genet Genomics; 2015 Dec; 42(12):703-6. PubMed ID: 26743988
[No Abstract] [Full Text] [Related]
23. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
Bellver Capella V
Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
[TBL] [Abstract][Full Text] [Related]
24. Plant Genome Editing Using FnCpf1 and LbCpf1 Nucleases at Redefined and Altered PAM Sites.
Zhong Z; Zhang Y; You Q; Tang X; Ren Q; Liu S; Yang L; Wang Y; Liu X; Liu B; Zhang T; Zheng X; Le Y; Zhang Y; Qi Y
Mol Plant; 2018 Jul; 11(7):999-1002. PubMed ID: 29567452
[No Abstract] [Full Text] [Related]
25. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
[TBL] [Abstract][Full Text] [Related]
26. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
28. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
[No Abstract] [Full Text] [Related]
29. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
[No Abstract] [Full Text] [Related]
30. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lescarbeau RM; Murray B; Barnes TM; Bermingham N
Nat Methods; 2018 Apr; 15(4):237. PubMed ID: 29600988
[No Abstract] [Full Text] [Related]
31. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
32. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
33. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
Liu G; Li J; Godwin ID
Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
[TBL] [Abstract][Full Text] [Related]
34. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
Verhage L
Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
[No Abstract] [Full Text] [Related]
35. CRISPR-Cas9-mediated genome editing in apple and grapevine.
Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
[TBL] [Abstract][Full Text] [Related]
36. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
37. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
38. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
Front Immunol; 2018; 9():1711. PubMed ID: 30233563
[TBL] [Abstract][Full Text] [Related]
39. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
Yang F; Li Y
Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
[TBL] [Abstract][Full Text] [Related]
40. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]